Evidence map›Paper›PMID 39269457›Full record

ArticleBrain : a journal of neurology2025

Decision cost hypersensitivity underlies Huntington's disease apathy.

Lee-Anne Morris, Kyla-Louise Horne, Sanjay Manohar, Laura Paermentier, Christina M Buchanan, Michael R MacAskill, Daniel J Myall, Matthew Apps, Richard Roxburgh, Tim J Anderson and 2 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Goal-directedness deficit in Huntington's disease.Cognitive, affective & behavioral neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lee-Anne MorrisDepartment of Medicine, University of Otago, Christchurch 8011, New Zealand.ORCID 0000-0002-8327-743X
Kyla-Louise HorneDepartment of Medicine, University of Otago, Christchurch 8011, New Zealand.
Sanjay ManoharDepartment of Experimental Psychology, University of Oxford, Oxford OX2 6GG, UK.
Laura PaermentierNew Zealand Brain Research Institute, Christchurch 8011, New Zealand.
Christina M BuchananDepartment of Neurology, Auckland City Hospital, Te Whatu Ora Health New Zealand, Auckland 1023, New Zealand.
Michael R MacAskillNew Zealand Brain Research Institute, Christchurch 8011, New Zealand.
Daniel J MyallNew Zealand Brain Research Institute, Christchurch 8011, New Zealand.
Matthew AppsCentre for Human Brain Health, School of Psychology, University of Birmingham, Birmingham B15 2SQ, UK.
Richard RoxburghDepartment of Neurology, Auckland City Hospital, Te Whatu Ora Health New Zealand, Auckland 1023, New Zealand.
Tim J AndersonDepartment of Medicine, University of Otago, Christchurch 8011, New Zealand.
Masud HusainDepartment of Experimental Psychology, University of Oxford, Oxford OX2 6GG, UK.ORCID 0000-0002-6850-9255
Campbell J Le HeronDepartment of Medicine, University of Otago, Christchurch 8011, New Zealand.

Funding

Canterbury Medical Research FoundationGreen Templeton CollegeUniversity of OtagoUniversity of OxfordUniversity of Oxford Clarendon FundWellcome Trust
6 · The paper itself

Abstract

The neuropsychiatric syndrome of apathy is now recognized to be a common and disabling condition in Huntington's disease. However, the mechanisms underlying it are poorly understood. One way to investigate apathy is to use a theoretical framework of normal motivated behaviour, to determine where breakdown has occurred in people with this behavioural disruption. A fundamental computation underlying motivated, goal-directed behaviour across species is weighing up the costs and rewards associated with actions. Here, we asked whether people with apathy are more sensitive to costs of actions (physical effort and time delay), less sensitive to rewarding outcomes, or both. Based on the unique anatomical substrates associated with Huntington's disease pathology, we hypothesized that a general hypersensitivity to costs would underpin Huntington's disease apathy. Genetically confirmed carriers of the expanded Huntingtin gene (premanifest to mild motor manifest disease, n = 53) were compared to healthy controls (n = 38). Participants performed a physical effort-based decision-making task (Apple Gathering Task) and a delay discounting task (Money Choice Questionnaire). Choice data was analysed using linear regression and drift diffusion models that also accounted for the time taken to make decisions. Apathetic people with Huntington's disease accepted fewer offers overall on the Apple Gathering Task, specifically driven by increased sensitivity to physical effort costs, and not explained by motor severity, mood, cognition or medication. Drift diffusion modelling provided further evidence of effort hypersensitivity, with apathy associated with a faster drift rate towards rejecting offers as a function of varying effort. Increased delay sensitivity was also associated with apathy, both when analysing raw choice and drift rate, where there was moderate evidence of Huntington's disease apathy drifting faster towards the immediately available (low-cost) option. Furthermore, the effort and delay sensitivity parameters from these tasks were positively correlated. The results demonstrate a clear mechanism for apathy in Huntington's disease, cost hypersensitivity, which manifests in both the effort and time costs associated with actions towards rewarding goals. This suggests that Huntington's disease pathology may cause a domain-general disruption of cost processing, which is distinct from apathy occurrence in other brain disorders and may require different therapeutic approaches.

Indexed as

ApathyDecision MakingHuntington DiseaseAdultAgedChoice BehaviorFemaleHumansHuntingtin ProteinMaleMiddle AgedMotivationRewardHuntingtin Proteinapathydecision-makingdelayeffortHuntington’s disease

Identifiers

PMID39269457
PMCPMC11884755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.